Werner; Douglas S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Werner; Douglas S..The latest application filed is for "silanol based therapeutic payloads".
Company Profile
2.19.29
- Werner; Douglas S. - West Palm Beach FL
- Werner; Douglas S. - Babylon NY
- Werner; Douglas S. - Holtsville NY US
- Werner; Douglas S. - Hollsville NY
- Werner; Douglas S. - Farmingdale NY
- Werner; Douglas S. - Northport NY
Patent Activity
| Patent | Date |
|---|---|
| Silanol Based Therapeutic Payloads App 20220184104 - Nguyen; Hanh Nho ; et al. | 2022-06-16 |
| Silicon based drug conjugates and methods of using same Grant 11,291,731 - Foreman , et al. April 5, 2 | 2022-04-05 |
| Silanol Based Therapeutic Payloads App 20210161921 - Nguyen; Hanh Nho ; et al. | 2021-06-03 |
| Silanol based therapeutic payloads Grant 10,716,801 - Nguyen , et al. | 2020-07-21 |
| Silicon Based Drug Conjugates And Methods Of Using Same App 20190290771 - Foreman; Kenneth W. ; et al. | 2019-09-26 |
| Silanol Based Therapeutic Payloads App 20190183913 - Nguyen; Hanh Nho ; et al. | 2019-06-20 |
| Silanol based therapeutic payloads Grant 10,293,053 - Nguyen , et al. | 2019-05-21 |
| Silanol Based Therapeutic Payloads App 20190111142 - Nguyen; Hanh N. ; et al. | 2019-04-18 |
| Silanol based therapeutic payloads Grant 10,064,880 - Nguyen , et al. September 4, 2 | 2018-09-04 |
| Silanol Based Therapeutic Payloads App 20180200273 - Nguyen; Hanh N. ; et al. | 2018-07-19 |
| Silicon based drug conjugates and methods of using same Grant 9,931,407 - Foreman , et al. April 3, 2 | 2018-04-03 |
| Silicon Based Drug Conjugates And Methods Of Using Same App 20170202970 - Foreman; Kenneth W. ; et al. | 2017-07-20 |
| Monomers Capable Of Multimerizing In An Aqueous Solution That Employ Bioorthogonal Chemistries, And Methods Of Using Same App 20150087043 - Arnold; Lee Daniel ; et al. | 2015-03-26 |
| Bromodomain Ligands Capable Of Dimerizing In An Aqueous Solution, And Methods Of Using Same App 20140243286 - Arnold; Lee Daniel ; et al. | 2014-08-28 |
| Bivalent Bromodomain Ligands, And Methods Of Using Same App 20140243322 - Arnold; Lee Daniel ; et al. | 2014-08-28 |
| Bioorthogonal Monomers Capable Of Dimerizing And Targeting Bromodomains, And Methods Of Using Same App 20140243321 - Arnold; Lee Daniel ; et al. | 2014-08-28 |
| Fused bicyclic mTOR inhibitors Grant 8,796,455 - Chen , et al. August 5, 2 | 2014-08-05 |
| 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,735,405 - Arnold , et al. May 27, 2 | 2014-05-27 |
| FUSED BICYCLIC mTOR INHIBITORS App 20130165651 - Chen; Xin ; et al. | 2013-06-27 |
| Fused bicyclic motor inhibitors Grant 8,314,111 - Chen , et al. November 20, 2 | 2012-11-20 |
| 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120196847 - Arnold; Lee D. ; et al. | 2012-08-02 |
| 2-aminopyridine kinase inhibitors Grant 8,178,668 - Steinig , et al. May 15, 2 | 2012-05-15 |
| Process For Substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines App 20120108812 - Dong; Hanqing ; et al. | 2012-05-03 |
| 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120077979 - Arnold; Lee D. ; et al. | 2012-03-29 |
| 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,101,613 - Arnold , et al. January 24, 2 | 2012-01-24 |
| Fused Bicyclic mTOR Inhibitors App 20110218183 - Chen; Xin ; et al. | 2011-09-08 |
| FUSED BICYCLIC mTOR INHIBITORS App 20110190496 - Chen; Xin ; et al. | 2011-08-04 |
| Fused bicyclic mTOR inhibitors Grant 7,943,767 - Chen , et al. May 17, 2 | 2011-05-17 |
| Fused bicyclic mTor inhibitors Grant 7,923,555 - Chen , et al. April 12, 2 | 2011-04-12 |
| 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 7,820,662 - Arnold , et al. October 26, 2 | 2010-10-26 |
| FUSED BICYCLIC mTOR INHIBITORS App 20100099679 - Chen; Xin ; et al. | 2010-04-22 |
| Fused bicyclic mTOR inhibitors Grant 7,700,594 - Chen , et al. April 20, 2 | 2010-04-20 |
| Unsaturated mTOR inhibitors Grant 7,659,274 - Crew , et al. February 9, 2 | 2010-02-09 |
| Bicyclic protein kinase inhibitors Grant 7,648,987 - Crew , et al. January 19, 2 | 2010-01-19 |
| 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20090325928 - Arnold; Lee D. ; et al. | 2009-12-31 |
| 2-aminopyridine Kinase Inhibitors App 20090197862 - Steinig; Arno G. ; et al. | 2009-08-06 |
| 2-ARYL pyrrologpyrimidines for A1 and A3 receptors App 20090192177 - Castelhano; Arlindo L. ; et al. | 2009-07-30 |
| Fused Bicyclic mTor Inhibitors App 20090163468 - Chen; Xin ; et al. | 2009-06-25 |
| 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20090118499 - Arnold; Lee D. ; et al. | 2009-05-07 |
| Compounds specific to adenosine A.sub.1 and A.sub.3 receptors and uses thereof Grant 7,504,407 - Castelhano , et al. March 17, 2 | 2009-03-17 |
| Unsaturated mTOR inhibitors App 20070254883 - Crew; Andrew Philip ; et al. | 2007-11-01 |
| Bicyclic protein kinase inhibitors App 20070149521 - Crew; Andrew Philip ; et al. | 2007-06-28 |
| Fused bicyclic mTOR inhibitors App 20070112005 - Chen; Xin ; et al. | 2007-05-17 |
| 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors App 20060235031 - Arnold; Lee D. ; et al. | 2006-10-19 |
| Compounds specific to adenosine a1 and a3 receptors and uses thereof App 20050090513 - Castelhano, Arlindo L. ; et al. | 2005-04-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 